EARLY - PHASE CLINICAL RESEARCH

About Us

Our CRS Team

Based in the European Union, fully GCP compliant, with a dedicated Phase I unit of up to 72+ participants.

About Us

CRS d.o.o. is a European clinical research organization headquartered in Slovenia, providing dedicated support for early-phase clinical studies in healthy volunteers.
With more than 20 years of experience, we work with pharmaceutical companies, biotechnology innovators, and development partners to generate reliable clinical pharmacology data within the European regulatory environment.
Our operations are centered around a dedicated Phase I clinical unit and an experienced multidisciplinary team. By combining structured processes, regulatory coordination, and hands-on clinical operations, we support the safe and consistent conduct of early-phase studies aligned with sponsor objectives.

Our Focus

CRS focuses on early-phase clinical studies where controlled execution, data integrity, and clear collaboration are essential. Our work is designed to support early development decisions without unnecessary operational complexity.

Our Vision

To be a trusted European Phase I partner for sponsors advancing early clinical programs through transparent collaboration and dependable study conduct.

Our Mission

To support early-phase clinical development by providing structured clinical operations, regulatory alignment, and consistent communication throughout the study lifecycle.

Evelina Turk, M. Pharm.  
Business Development Manager & CRA

TMF Specialist & Site Operations Expert while also assisting in business development and projects. 5+ Years of experience in clinical research

Our CRS Team

Meet our core team of experts at CRS d.o.o., who have been with us from our beginnings.

Tanja Turk, M. Pharm.
Clinical Research Scientist & CEO

Founder & CEO of CRS, Leading and supporting clinical operations in region. Tanja has more than 25 years of experience in clinical research.

Aleksander Turk, MSC
Data Management Lead

Co-founder and senior expert in EDC systems and clinical data validation, with more than 25 years of experience ensuring data integrity across clinical studies.

Filip Turk, MSC
Study Coordinatior & Data Manager

Experienced in study coordination, site and subject oversight, visit tracking, eCRF design, data validation, and end-to-end clinical data operations.

Snežana Ulčar Kostič, MD, PhD
Our Safety
Lead Monitor

Provides medical safety oversight, including AE/SAE review and GCP-compliant safety reporting across clinical studies.

Matjaž Fležar, MD, PhD
Principal Investigator, Specialising in Pulmonology

Leads clinical studies in pulmonology with a focus on subject safety, protocol compliance, and data quality.

Andrej Kravos, MD, PhD
Principal Investigator,
General Practice Specialist

Conducts clinical studies from screening to completion, ensuring high-quality data and patient safety.

20+ Years

Of Experience in Early-Phase Clinical Research

Phase I Unit

Infrastructure organized across two dedicated units for controlled inpatient studies

EU Certified CRO

Slovenia, European Union regulatory environment

GCP Compliant

Conduct under international quality standards